Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01780064
Other study ID # APAPI-1202
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 2013
Est. completion date January 2018

Study information

Verified date June 2024
Source Centre Oscar Lambret
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work


Description:

For the group "intervention", patients have four interviews with a psychologist (at cure one of chemotherapy treatment, at cure six of chemotherapy treatment, at last radiotherapy session, and three months after the end of radiotherapy). In the 2 arms, patients receive 4 sets of questionnaires (baseline, month 12, month 18 and month 24)


Recruitment information / eligibility

Status Terminated
Enrollment 128
Est. completion date January 2018
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Women = 18 with work at the time of diagnosis - Presenting a unilateral breast cancer exclusively local extension - Having received surgery - Reporting of adjuvant chemotherapy (+ / - trastuzumab) - Reporting to radiotherapy or not (If radiotherapy, it will be done on site investigator) - In work at the time of diagnosis (employees, traders and professionals) - Patient affiliated to a social security scheme - Consent signed by the patient before the implementation of any specific procedure to study Exclusion Criteria: - Presence of in situ lesions, cancer recurrence, metastatic disease immediately, location bilateral - Inability physical, psychological, psychiatric or cognitive responses to the questionnaires and participate in interviews - Recognition previous ALD (due to another disease) - Patient under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
interviews with a psychologist
interviews with a psychologist
Questionnaires
Questionnaires

Locations

Country Name City State
France Centre Marie Curie Arras
France Centre Pierre Curie Beuvry
France Centre Léonard de Vinci Dechy
France Centre Oscar Lambret Lille
France Centre Hospitalier Valenciennes
France Nouvelle Clinique des Dentellières Valenciennes
France Hôpital Privé de Villeneuve d'Ascq Villeneuve d'Ascq

Sponsors (2)

Lead Sponsor Collaborator
Centre Oscar Lambret University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work At 24 months
Secondary Comparison between the two modes of care, of social inequalities: On the quality of the return to employment (working conditions, job stability)
On individual and collective resources of patients (social encouragement received, reactions to issues, anxiety/depression, quality of life, etc)
At 24 months
Secondary Calculating the cost / benefit ratio of the two modes of care At 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2